Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10933073 Compositions and methods comprising a psilocybin derivative

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 9, 2018
0
Date of Patent
March 2, 2021
0
Patent Application Number
15893562
0
Patent Citations Received
‌
US Patent 12110272 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11974984 Compositions and methods comprising a combination of serotonergic drugs
0
‌
US Patent 12012380 Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulators
0
‌
US Patent 12104179 Genetically modified organisms for producing psychotropic alkaloids
0
‌
US Patent 11471439 Compositions and methods comprising a combination of serotonergic drugs
‌
US Patent 11746088 Deuterated tryptamine derivatives and methods of use
‌
US Patent 11332441 Crystalline N-methyl tryptamine derivatives
‌
US Patent 11780807 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor
‌
US Patent 11834410 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11905535 Genetic engineering of fungi to modulate tryptamine expression
0
•••
Patent Inventor Names
Andrew R. Chadeayne
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10933073
0
Patent Primary Examiner
‌
James D. Anderson
0

Find more entities like US Patent 10933073 Compositions and methods comprising a psilocybin derivative

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.